Author Question: If a researcher suspects that treatment may be effective for some participants and it may not be ... (Read 48 times)

yoroshambo

  • Hero Member
  • *****
  • Posts: 566
If a researcher suspects that treatment may be effective for some participants and it may not be effective for other participants, using between-subjects group comparison designs
 
  A) may obscure the effect by averaging the scores of the individuals in the group.
  B) will allow the researcher to determine the effect of treatment on the individual as well as the group.
  C) will allow the researcher to determine the effect of treatment on the individual, but will obscure the effect on the group.
  D) is unethical because there may be participants who are not cured.

Question 2

If a between-subjects, group comparison design was used to evaluate a treatment in which some participants in the experimental group improved, some remained the same, and some became worse, the researcher would most likely conclude
 
  A) the treatment is effective.
  B) the treatment is not effective.
  C) the treatment is more effective for the control group than for the experimental group.
  D) there is a significant difference between the experimental and control groups.



firehawk60

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

Answer: A

Answer to Question 2

Answer: B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

The average office desk has 400 times more bacteria on it than a toilet.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

For a complete list of videos, visit our video library